INTRODUCTION
Yinlai Decoction (YD) is an empirical formula used to treat lung and stomach diseases, especially pneumonia and recurrent respiratory tract infections in children. This traditional formula is composed of Lonicerae japonicae Flos, Raphani semen, Forsythiae fructus, Scutellariae radix, Houttuyniae herba, Peucedani radix and Trichosanthes kirilowii Maxim [1] .
Biological mechanisms of YD have been related to the regulation of expression of inflammatory factors, such as tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) [2] [3] [4] . Moreover, the existing experimental data is either fragmented or confined to a single index or one pathway, thus it cannot reflect the overall multi-target regulation of this traditional Chinese medicine's characteristics.
On account of this deficiency in knowledge, we have introduced system theory as an attempt to explore the possible mechanism of YD. Network pharmacology is an emerging discipline, which is useful to study the progression of disease, the interaction of drug with the body and the discovery of new drugs from the perspective of biological networks [5] . The basic idea of network pharmacology is to intervene the pathological network of disease, rather than just individual genes associated with disease, to achieve a comprehensive prevention and treatment effects.
By analyzing the existing databases, we sorted out all chemical ingredients present in YD. Targets of all these chemical molecules were identified, and then the related pathways or diseases for each target were annotated. Through correlation and pathway analysis of targets related to the lung and stomach diseases treatable with YD, we predicted network-based mechanism of YD for related diseases.
METHODS

Database construction
Traditional
Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP, http://lsp.nwsuaf.edu.cn/tcmsp.php) is a unique platform of system pharmacology for Chinese herbal medicines that that renders a relationship between drugs, molecular targets and diseases states. This database is not only accompanying with various pharmacological networks, but also exhibits pharmacokinetic features of natural drugs such as solubility, permeability and bioavailability. This advancement has initiated a new thematic search to find candidate drugs in different types of traditional Chinese herbs [6] . All chemicals of each herb and all targets of each chemical were retrieved through TCMSP and the available literature. Specific retrieval steps were: (i) retrieval of YD ingredients; (ii) target search of each chemical, then (iii) building of chemicaltargets database of YD.
Target identification
A target-disease database was developed after retrieval of the related diseases of each target through TCMSP. Afterwards, the corresponding molecular targets of these chemical ingredients were identified for further analysis.
Network construction and analysis
For systematic investigation of mechanism of YD, the interaction between these molecular targets were analyzed through Search Tool for the Retrieval of Interacting Genes / Proteins (STRING, http://string-db.org/). STRING database is an excellent source of hundreds of known interactions between proteins as well as is capable of predicting interactions. This database retrieves the knowledge of both physical (direct) and functional (indirect) interactions from four different sources of information such as genomic literature, high-throughput screening, coexpression and the published information. STRING combines the interaction data from these sources for hundreds of organisms, and transfers information between these organisms where applicable. This database presently covers 9,643,763 proteins from 2,031 organisms [7] .
The relationship between herbs and the screened targets was analyzed by constructing target-herb network to investigate the mechanism of YD and its significance of pharmacodynamic composition. The network was generated by Cytoscape 3.4.0 [8] .
Gene ontology and pathway enrichment analysis
In order to identify and analyze the specific biological properties of the potential targets, Gene Ontology (GO) biological processes were introduced to dissect target genes in a hierarchically structured way based on the characteristic biological terms. Pathway enrichment analysis was introduced to probe the mechanisms of YD for related diseases. Both GO terms and KEGG pathway terms were obtained from STRING. Then, more information of these pathways were acquired from Kyoto Encyclopedia of Genes and Genomes (KEGG, http://www.kegg.jp/) database.
RESULTS
Herb-compound-target database
A total of 236 molecular compounds in Lonicerae japonicae Flos and 388 potential targets, 52 molecular compounds in Raphani semen and 103 targets, 80 molecular compounds in Forsythiae fructus and 323 targets, 58 molecular compounds in Scutellariae radix and 197 targets, 208 molecular compounds in Houttuyniae herba and 50 targets, 101 molecular compounds in Peucedani radix and 369 targets, and 150 molecular compounds and 362 targets in Trichosanthes kirilowii Maxim were obtained. Chemical compounds and their targets were merged to remove overlapping. As a result, 627 molecular compounds and 654 potential targets in YD were found.
Targets and the related diseases
According to early experimental results and clinical applications, YD could be used to treat inflammation, respiratory diseases and bacterial and viral infections. Out of 654 targets of YD, 38 targets related to these diseases screened out and mapped to the database UniProt (http://www.uniprot.org/) for normalization.
Out of these 38, 33 protein targets were found to exist in Homo sapiens (Table 1) . Betalactamases (β-lactamases) are enzymes (EC 3.5.2.6) produced by bacteria that provide resistance to β-lactam antibiotics such as the penicillins, cephamycins, and carbapenems. 
Target-target interaction (T-T) networks
The protein interaction network of 33 target genes was constructed using STRING ( Figure 1 ). Genes were denoted as nodes and interactions between gene pairs were presented as edges (lines) in the image. A total of 33 nodes and 127 edges composed the acquired interaction network. The degree of each node is shown in Table 2 . Average node degree and the clustering coefficient were 7.7 and 0.617, respectively for this network having no PPI enrichment value. In the network, the degree of node (the number of connections or edges the node has with other nodes) is one of the most basic quantitative properties and the nodes with high degree are considered as hubs. Of the 33 proteins, 15 proteins possess node degree larger than 8 under an average value of 7.7, therefore, these candidate proteins participating in more interactions than other proteins are the hubs in this T-T Network. In the network, TNF (Tumor necrosis factor) was the node with the highest degree (DD = 19), followed by PTGS2 (Prostaglandin G/H 
Herb-target networks
For further studying the relationship between targets and herbs, we constructed herb-target network using Cytoscape (Figure2). The information of the related targets-herbs are shown in Table 3 . In the network, PTGS2, PTGS1, IL6, NOS3, ADRB2, TNF, TOP2 and CHRM2 were the nodes with the highest degree (DD = 7), followed by PPARG, LTA4H, ALOX5 and PPARD (DD = 6), CDK2, CCL2, IL1B, VEGFA, OPRM1, ODC1, ACACA (DD = 5), MAPK14, TXNRD1, MAPK8, SELE and F3 (DD = 4). 
Go and pathway analysis data
To analyze biological functions of these potential targets, GO and Pathway enrichment analysis was conducted. We obtained 576 GO terms (Biological Process) and 75 KEGG pathways (False Discovery Rate, FDR < 0.05) ( Table 4) . It is interesting to note that these targets are involved in a variety of biological processes including response to oxygen-containing compound and regulation of cell proliferation, response to bacterium. These biological processes are largely related to transcriptional regulation, immune response, and apoptosis. It indicates that these biological processes have a close relationship with inflammation. Of 75 KEGG pathway terms, TNF signaling pathway, NOD-like receptor signaling pathway, influenza A and toll-like receptor signaling pathway have the lowest FDR. Four pathways are associated with virus infection, immune tolerance, immune response and inflammatory response, which play an important role in respiratory infection diseases.
DISCUSSION
YD is effective in amiolerating lung condition, relieving exterior syndrome, relaxing the bowels and removing food retention, and has been used for treating pediatric diseases, especially pneumonia and recurrent respiratory tract infection [9] [10] [11] [12] [13] [14] .
However, the precise mechanisms of YD action in these diseases are still unclear. Thus, system pharmacology method combining the screening drug targeting, network construction, and pathway analysis was carried out in this work to uncover the active ingredients, targets, and pathways of YD and systematically deciphered its therapeutic mechanism of actions [15] . Our results showed that 627 ingredients and 654 potential targets were obtained from YD, and 37 targets were screened out. GO analysis of these targets and integrated herb-target network analysis demonstrated the synergistic e ect of YD ingredients in treating the related diseases mainly through boosting of immune system, inhibiting inflammatory response, and inhibiting/killing pathogens as well as decreasing drug resistance [15] . Meanwhile, the pathway analysis in our work shows that YD might simultaneously regulate multitargets/pathways coupled with a range of therapeutic modules, for example, the suppression of inflammation and virus/bacterial infections and decreasing drug resistance [12] . Previous studies have shown that YD could boost immune system, inhibit inflammatory response and ease the damage caused by inflammation through reduction of expression of IL-6 and TNF-α and increasing the expression of IL-2, IL-10, IFN-γ, SIgA and IgM [3] . In this study, GO enrichment analysis, network analysis and pathway analysis exhibited that YD significantly enriches target genes involved in reducing the inflammation response, enhancing immunity and combating viral/bacterial growth.
Zheng and Chen Bai contributed equally to this article.
Open Access
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/rea d), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
